vs

Side-by-side financial comparison of Envela Corp (ELA) and GLAUKOS Corp (GKOS). Click either name above to swap in a different company.

GLAUKOS Corp is the larger business by last-quarter revenue ($150.6M vs $80.5M, roughly 1.9× Envela Corp). Envela Corp runs the higher net margin — 7.4% vs 6.2%, a 1.2% gap on every dollar of revenue. On growth, Envela Corp posted the faster year-over-year revenue change (66.6% vs 41.2%). Over the past eight quarters, Envela Corp's revenue compounded faster (42.1% CAGR vs 25.4%).

Envela Corporation is a U.S.-based company that provides recommerce services aimed at extending product lifecycles and reducing resource consumption. The company operates through two primary segments: consumer and commercial.

Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.

ELA vs GKOS — Head-to-Head

Bigger by revenue
GKOS
GKOS
1.9× larger
GKOS
$150.6M
$80.5M
ELA
Growing faster (revenue YoY)
ELA
ELA
+25.4% gap
ELA
66.6%
41.2%
GKOS
Higher net margin
ELA
ELA
1.2% more per $
ELA
7.4%
6.2%
GKOS
Faster 2-yr revenue CAGR
ELA
ELA
Annualised
ELA
42.1%
25.4%
GKOS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ELA
ELA
GKOS
GKOS
Revenue
$80.5M
$150.6M
Net Profit
$6.0M
$9.4M
Gross Margin
20.5%
77.9%
Operating Margin
9.4%
9.0%
Net Margin
7.4%
6.2%
Revenue YoY
66.6%
41.2%
Net Profit YoY
274.6%
EPS (diluted)
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ELA
ELA
GKOS
GKOS
Q1 26
$150.6M
Q4 25
$80.5M
$143.1M
Q3 25
$57.4M
$133.5M
Q2 25
$54.9M
$124.1M
Q1 25
$48.3M
$106.7M
Q4 24
$48.3M
$105.5M
Q3 24
$46.9M
$96.7M
Q2 24
$45.3M
$95.7M
Net Profit
ELA
ELA
GKOS
GKOS
Q1 26
$9.4M
Q4 25
$6.0M
$-133.7M
Q3 25
$3.4M
$-16.2M
Q2 25
$2.8M
$-19.7M
Q1 25
$2.5M
$-18.1M
Q4 24
$1.6M
$-33.6M
Q3 24
$1.7M
$-21.4M
Q2 24
$1.6M
$-50.5M
Gross Margin
ELA
ELA
GKOS
GKOS
Q1 26
77.9%
Q4 25
20.5%
-1.1%
Q3 25
22.8%
78.4%
Q2 25
22.6%
78.3%
Q1 25
24.8%
77.2%
Q4 24
23.1%
72.9%
Q3 24
24.4%
76.6%
Q2 24
25.1%
76.4%
Operating Margin
ELA
ELA
GKOS
GKOS
Q1 26
9.0%
Q4 25
9.4%
-97.7%
Q3 25
7.3%
-12.3%
Q2 25
5.9%
-18.3%
Q1 25
6.5%
-19.4%
Q4 24
3.9%
-27.2%
Q3 24
4.3%
-25.5%
Q2 24
4.2%
-31.3%
Net Margin
ELA
ELA
GKOS
GKOS
Q1 26
6.2%
Q4 25
7.4%
-93.4%
Q3 25
5.8%
-12.2%
Q2 25
5.0%
-15.8%
Q1 25
5.2%
-17.0%
Q4 24
3.3%
-31.8%
Q3 24
3.6%
-22.1%
Q2 24
3.5%
-52.8%
EPS (diluted)
ELA
ELA
GKOS
GKOS
Q1 26
Q4 25
$0.22
$-2.34
Q3 25
$0.13
$-0.28
Q2 25
$0.11
$-0.34
Q1 25
$0.10
$-0.32
Q4 24
$0.07
$-0.56
Q3 24
$0.06
$-0.39
Q2 24
$0.06
$-1.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ELA
ELA
GKOS
GKOS
Cash + ST InvestmentsLiquidity on hand
$276.7M
Total DebtLower is stronger
$9.9M
Stockholders' EquityBook value
$67.1M
$670.9M
Total Assets
$96.0M
$893.3M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ELA
ELA
GKOS
GKOS
Q1 26
$276.7M
Q4 25
$90.8M
Q3 25
$98.2M
Q2 25
$100.8M
Q1 25
$114.3M
Q4 24
$169.6M
Q3 24
$100.1M
Q2 24
$68.1M
Total Debt
ELA
ELA
GKOS
GKOS
Q1 26
Q4 25
$9.9M
Q3 25
$12.5M
Q2 25
$13.0M
Q1 25
$13.2M
Q4 24
$13.5M
Q3 24
$13.8M
Q2 24
$14.3M
Stockholders' Equity
ELA
ELA
GKOS
GKOS
Q1 26
$670.9M
Q4 25
$67.1M
$656.2M
Q3 25
$61.1M
$769.5M
Q2 25
$57.8M
$765.1M
Q1 25
$55.1M
$764.0M
Q4 24
$52.7M
$766.9M
Q3 24
$51.1M
$668.5M
Q2 24
$50.2M
$665.2M
Total Assets
ELA
ELA
GKOS
GKOS
Q1 26
$893.3M
Q4 25
$96.0M
$893.5M
Q3 25
$90.9M
$999.4M
Q2 25
$82.7M
$987.0M
Q1 25
$79.7M
$966.2M
Q4 24
$77.9M
$974.8M
Q3 24
$77.4M
$926.5M
Q2 24
$73.8M
$919.7M
Debt / Equity
ELA
ELA
GKOS
GKOS
Q1 26
Q4 25
0.15×
Q3 25
0.20×
Q2 25
0.23×
Q1 25
0.24×
Q4 24
0.26×
Q3 24
0.27×
Q2 24
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ELA
ELA
GKOS
GKOS
Operating Cash FlowLast quarter
$-3.5M
Free Cash FlowOCF − Capex
$-3.7M
FCF MarginFCF / Revenue
-4.6%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
-0.59×
TTM Free Cash FlowTrailing 4 quarters
$1.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ELA
ELA
GKOS
GKOS
Q1 26
Q4 25
$-3.5M
$6.8M
Q3 25
$2.4M
$-10.1M
Q2 25
$2.6M
$7.0M
Q1 25
$1.1M
$-18.5M
Q4 24
$3.7M
$507.0K
Q3 24
$3.4M
$-9.6M
Q2 24
$-789.5K
$-18.4M
Free Cash Flow
ELA
ELA
GKOS
GKOS
Q1 26
Q4 25
$-3.7M
$3.9M
Q3 25
$2.2M
$-11.7M
Q2 25
$2.1M
$5.8M
Q1 25
$746.6K
$-20.5M
Q4 24
$3.2M
$-1.2M
Q3 24
$1.5M
$-11.0M
Q2 24
$-1.3M
$-20.5M
FCF Margin
ELA
ELA
GKOS
GKOS
Q1 26
Q4 25
-4.6%
2.7%
Q3 25
3.8%
-8.8%
Q2 25
3.9%
4.7%
Q1 25
1.5%
-19.2%
Q4 24
6.7%
-1.2%
Q3 24
3.1%
-11.4%
Q2 24
-2.9%
-21.4%
Capex Intensity
ELA
ELA
GKOS
GKOS
Q1 26
Q4 25
0.2%
2.0%
Q3 25
0.4%
1.2%
Q2 25
0.8%
0.9%
Q1 25
0.8%
1.8%
Q4 24
1.0%
1.6%
Q3 24
4.2%
1.5%
Q2 24
1.1%
2.2%
Cash Conversion
ELA
ELA
GKOS
GKOS
Q1 26
Q4 25
-0.59×
Q3 25
0.72×
Q2 25
0.94×
Q1 25
0.45×
Q4 24
2.34×
Q3 24
2.05×
Q2 24
-0.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ELA
ELA

Consumer Segment$67.7M84%
Commercial Segment$12.8M16%

GKOS
GKOS

Segment breakdown not available.

Related Comparisons